HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 36, 26665-26674, September 8, 2006

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 281/36/26665    most recent M602174200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holinstat, M. Articles by Hamm, H. E. Search for Related Content PubMed PubMed Citation Articles by Holinstat, M. Articles by Hamm, H. E. Social Bookmarking                      What's this?

PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca²⁺ Mobilization and Synergistic P2Y₁₂ Receptor Activation^*

Michael Holinstat, Bryan Voss, Matthew L. Bilodeau, Joseph N. McLaughlin^¶, John Cleator, and Heidi E. Hamm¹

From the Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600, the Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600, and the ^¶Department of Pharmacology, University of Illinois, Chicago, Illinois 60608

Regulation of platelet activation plays a central role in hemostasis and pathophysiological processes such as coronary artery disease. Thrombin is the most potent activator of platelets. Human platelets express two thrombin receptors, PAR1 and PAR4, both of which signal platelet activation. Evidence is lacking on the mechanism by which PAR1 and PAR4 may differentially signal platelet aggregation. Here we show that at the relatively high concentration of agonist most likely found at the site of a local thrombus, dual inhibition of the P2Y₁₂ receptor and calcium mobilization result in a complete inhibition of PAR4-induced aggregation, while having no effect on either thrombin or PAR1-mediated platelet aggregation. Both PAR1- and PAR4mediated aggregation are independent of calcium mobilization. Furthermore, we show that P2Y₁₂ receptor activation is not required for protease-activated receptor-mediated aggregation at higher agonist concentrations and is only partially required for Rap1 as well as GPIIbIIIa activation. P2Y₁₂ receptor inhibitors clinically in use such as clopidogrel are postulated to decrease platelet aggregation through partial inhibition of PAR1 signaling. Our data, however, indicate that at high local concentrations of thrombin, it is the signaling through PAR4 rather than PAR1 that may be regulated through purinergic feedback. Thus, our data identify an intra-platelet mechanism that may function as a future site for therapeutic intervention.

Received for publication, March 7, 2006 , and in revised form, July 10, 2006.

^* This work was supported by National Institutes of Health Grants HL084388 and EY010291 (to H. E. H.) and National Research Service Awards HL-076133-02 and HL-082068-01 (to M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.

¹ To whom correspondence should be addressed: Vanderbilt University Medical Center, 23rd Ave. South and Pierce, 442 Robinson Research Bldg., Nashville, TN 37232-6600. Tel.: 615-343-3533; Fax: 615-343-1084; E-mail: heidi.hamm{at}vanderbilt.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. M. Cifuni, D. D. Wagner, and W. Bergmeier CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin {alpha}IIb{beta}3 in platelets Blood, September 1, 2008; 112(5): 1696 - 1703. [Abstract] [Full Text] [PDF]

				M. Grenegard, K. Vretenbrant-Oberg, M. Nylander, S. Desilets, E. G. Lindstrom, A. Larsson, I. Ramstrom, S. Ramstrom, and T. L. Lindahl The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine J. Biol. Chem., July 4, 2008; 283(27): 18493 - 18504. [Abstract] [Full Text] [PDF]

				K. Hirano, N. Nomoto, M. Hirano, F. Momota, A. Hanada, and H. Kanaide Distinct Ca2+ Requirement for NO Production between Proteinase-Activated Receptor 1 and 4 (PAR1 and PAR4) in Vascular Endothelial Cells J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 668 - 677. [Abstract] [Full Text] [PDF]

				M. L. Bilodeau and H. E. Hamm Regulation of Protease-Activated Receptor (PAR) 1 and PAR4 Signaling in Human Platelets by Compartmentalized Cyclic Nucleotide Actions J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 778 - 788. [Abstract] [Full Text] [PDF]

				B. Voss, J. N. McLaughlin, M. Holinstat, R. Zent, and H. E. Hamm PAR1, but Not PAR4, Activates Human Platelets through a Gi/o/Phosphoinositide-3 Kinase Signaling Axis Mol. Pharmacol., May 1, 2007; 71(5): 1399 - 1406. [Abstract] [Full Text] [PDF]

				M. Holinstat, B. Voss, M. L. Bilodeau, and H. E. Hamm Protease-Activated Receptors Differentially Regulate Human Platelet Activation through a Phosphatidic Acid-Dependent Pathway Mol. Pharmacol., March 1, 2007; 71(3): 686 - 694. [Abstract] [Full Text] [PDF]

				A. Mazharian, S. Roger, E. Berrou, F. Adam, A. Kauskot, P. Nurden, M. Jandrot-Perrus, and M. Bryckaert Protease-activating Receptor-4 Induces Full Platelet Spreading on a Fibrinogen Matrix: INVOLVEMENT OF ERK2 AND p38 AND Ca2+ MOBILIZATION J. Biol. Chem., February 23, 2007; 282(8): 5478 - 5487. [Abstract] [Full Text] [PDF]